EURONEXT NV (ENX.PA) Fundamental Analysis & Valuation

EPA:ENX • NL0006294274

142.4 EUR
+1.5 (+1.06%)
Last: Mar 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This ENX.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Taking everything into account, ENX scores 5 out of 10 in our fundamental rating. ENX was compared to 117 industry peers in the Capital Markets industry. There are concerns on the financial health of ENX while its profitability can be described as average. ENX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. ENX.PA Profitability Analysis

1.1 Basic Checks

  • ENX had positive earnings in the past year.
  • In the past year ENX had a positive cash flow from operations.
  • In the past 5 years ENX has always been profitable.
  • ENX had a positive operating cash flow in each of the past 5 years.
ENX.PA Yearly Net Income VS EBIT VS OCF VS FCFENX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

1.2 Ratios

  • The Return On Assets of ENX (0.40%) is worse than 60.68% of its industry peers.
  • ENX has a Return On Equity of 28.78%. This is amongst the best in the industry. ENX outperforms 89.74% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 16.73%, ENX belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
Industry RankSector Rank
ROA 0.4%
ROE 28.78%
ROIC 16.73%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ENX.PA Yearly ROA, ROE, ROICENX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • ENX has a better Profit Margin (35.88%) than 80.34% of its industry peers.
  • ENX's Profit Margin has been stable in the last couple of years.
  • Looking at the Operating Margin, with a value of 51.96%, ENX belongs to the top of the industry, outperforming 86.32% of the companies in the same industry.
  • ENX's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 51.96%
PM (TTM) 35.88%
GM N/A
OM growth 3Y3.38%
OM growth 5Y-0.57%
PM growth 3Y4.63%
PM growth 5Y-0.18%
GM growth 3YN/A
GM growth 5YN/A
ENX.PA Yearly Profit, Operating, Gross MarginsENX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ENX.PA Health Analysis

2.1 Basic Checks

  • ENX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ENX.PA Yearly Shares OutstandingENX.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ENX.PA Yearly Total Debt VS Total AssetsENX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

2.2 Solvency

  • The Debt to FCF ratio of ENX is 5.20, which is a neutral value as it means it would take ENX, 5.20 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 5.20, ENX is doing good in the industry, outperforming 70.94% of the companies in the same industry.
  • A Debt/Equity ratio of 0.66 indicates that ENX is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ENX (0.66) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 5.2
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
ENX.PA Yearly LT Debt VS Equity VS FCFENX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

  • ENX has a Current Ratio of 1.00. This is a normal value and indicates that ENX is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.00, ENX is in line with its industry, outperforming 58.97% of the companies in the same industry.
  • ENX has a Quick Ratio of 1.00. This is a normal value and indicates that ENX is financially healthy and should not expect problems in meeting its short term obligations.
  • ENX has a Quick ratio (1.00) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
ENX.PA Yearly Current Assets VS Current LiabilitesENX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ENX.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 10.65% over the past year.
  • Measured over the past years, ENX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.84% on average per year.
  • ENX shows a strong growth in Revenue. In the last year, the Revenue has grown by 50.11%.
  • The Revenue has been growing by 15.51% on average over the past years. This is quite good.
EPS 1Y (TTM)10.65%
EPS 3Y11.89%
EPS 5Y9.84%
EPS Q2Q%9.04%
Revenue 1Y (TTM)50.11%
Revenue growth 3Y8.63%
Revenue growth 5Y15.51%
Sales Q2Q%12.39%

3.2 Future

  • ENX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.66% yearly.
  • The Revenue is expected to grow by 3.04% on average over the next years.
EPS Next Y6.89%
EPS Next 2Y7.74%
EPS Next 3Y4.87%
EPS Next 5Y6.66%
Revenue Next Year6.55%
Revenue Next 2Y5.94%
Revenue Next 3Y3.5%
Revenue Next 5Y3.04%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ENX.PA Yearly Revenue VS EstimatesENX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
ENX.PA Yearly EPS VS EstimatesENX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

5

4. ENX.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 19.59, the valuation of ENX can be described as rather expensive.
  • ENX's Price/Earnings is on the same level as the industry average.
  • ENX is valuated rather cheaply when we compare the Price/Earnings ratio to 26.29, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 18.33 indicates a rather expensive valuation of ENX.
  • Based on the Price/Forward Earnings ratio, ENX is valued a bit cheaper than the industry average as 65.81% of the companies are valued more expensively.
  • ENX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.57, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.59
Fwd PE 18.33
ENX.PA Price Earnings VS Forward Price EarningsENX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ENX indicates a rather cheap valuation: ENX is cheaper than 86.32% of the companies listed in the same industry.
  • ENX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ENX is cheaper than 80.34% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.56
EV/EBITDA 7.79
ENX.PA Per share dataENX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ENX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.84
PEG (5Y)1.99
EPS Next 2Y7.74%
EPS Next 3Y4.87%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ENX.PA Dividend Analysis

5.1 Amount

  • ENX has a Yearly Dividend Yield of 2.12%.
  • Compared to an average industry Dividend Yield of 3.11, ENX pays a bit more dividend than its industry peers.
  • ENX's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.12%

5.2 History

  • The dividend of ENX is nicely growing with an annual growth rate of 15.21%!
Dividend Growth(5Y)15.21%
Div Incr Years4
Div Non Decr Years4
ENX.PA Yearly Dividends per shareENX.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

  • ENX pays out 22.47% of its income as dividend. This is a sustainable payout ratio.
  • ENX's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP22.47%
EPS Next 2Y7.74%
EPS Next 3Y4.87%
ENX.PA Yearly Income VS Free CF VS DividendENX.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
ENX.PA Dividend Payout.ENX.PA Dividend Payout, showing the Payout Ratio.ENX.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ENX.PA Fundamentals: All Metrics, Ratios and Statistics

EURONEXT NV

EPA:ENX (3/6/2026, 7:00:00 PM)

142.4

+1.5 (+1.06%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-18
Earnings (Next)05-19
Inst Owners62.58%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap14.77B
Revenue(TTM)3.64B
Net Income(TTM)1.31B
Analysts71
Price Target150.16 (5.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.12%
Yearly Dividend1.89
Dividend Growth(5Y)15.21%
DP22.47%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.17%
Min EPS beat(2)1.23%
Max EPS beat(2)7.11%
EPS beat(4)4
Avg EPS beat(4)3.6%
Min EPS beat(4)1.23%
Max EPS beat(4)7.11%
EPS beat(8)8
Avg EPS beat(8)4.64%
EPS beat(12)12
Avg EPS beat(12)5.76%
EPS beat(16)15
Avg EPS beat(16)5.22%
Revenue beat(2)1
Avg Revenue beat(2)0.32%
Min Revenue beat(2)-1.77%
Max Revenue beat(2)2.41%
Revenue beat(4)3
Avg Revenue beat(4)0.41%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)2.41%
Revenue beat(8)6
Avg Revenue beat(8)0.33%
Revenue beat(12)7
Avg Revenue beat(12)0.04%
Revenue beat(16)10
Avg Revenue beat(16)11.45%
PT rev (1m)-1.06%
PT rev (3m)-0.93%
EPS NQ rev (1m)2.08%
EPS NQ rev (3m)-0.7%
EPS NY rev (1m)0%
EPS NY rev (3m)0.81%
Revenue NQ rev (1m)2.62%
Revenue NQ rev (3m)3.43%
Revenue NY rev (1m)1.09%
Revenue NY rev (3m)1.4%
Valuation
Industry RankSector Rank
PE 19.59
Fwd PE 18.33
P/S 4.06
P/FCF 22.56
P/OCF 18.18
P/B 3.25
P/tB N/A
EV/EBITDA 7.79
EPS(TTM)7.27
EY5.11%
EPS(NY)7.77
Fwd EY5.46%
FCF(TTM)6.31
FCFY4.43%
OCF(TTM)7.83
OCFY5.5%
SpS35.1
BVpS43.76
TBVpS-21.6
PEG (NY)2.84
PEG (5Y)1.99
Graham Number84.61
Profitability
Industry RankSector Rank
ROA 0.4%
ROE 28.78%
ROCE 22.72%
ROIC 16.73%
ROICexc 20.89%
ROICexgc N/A
OM 51.96%
PM (TTM) 35.88%
GM N/A
FCFM 17.98%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y3.38%
OM growth 5Y-0.57%
PM growth 3Y4.63%
PM growth 5Y-0.18%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 5.2
Debt/EBITDA 1.43
Cap/Depr 78.84%
Cap/Sales 4.33%
Interest Coverage 53.42
Cash Conversion 38.84%
Profit Quality 50.12%
Current Ratio 1
Quick Ratio 1
Altman-Z N/A
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)61.87%
Cap/Depr(5y)60.3%
Cap/Sales(3y)7%
Cap/Sales(5y)6.65%
Profit Quality(3y)116.23%
Profit Quality(5y)116.39%
High Growth Momentum
Growth
EPS 1Y (TTM)10.65%
EPS 3Y11.89%
EPS 5Y9.84%
EPS Q2Q%9.04%
EPS Next Y6.89%
EPS Next 2Y7.74%
EPS Next 3Y4.87%
EPS Next 5Y6.66%
Revenue 1Y (TTM)50.11%
Revenue growth 3Y8.63%
Revenue growth 5Y15.51%
Sales Q2Q%12.39%
Revenue Next Year6.55%
Revenue Next 2Y5.94%
Revenue Next 3Y3.5%
Revenue Next 5Y3.04%
EBIT growth 1Y56.19%
EBIT growth 3Y12.31%
EBIT growth 5Y14.86%
EBIT Next Year19.49%
EBIT Next 3Y10.17%
EBIT Next 5Y6.16%
FCF growth 1Y5.33%
FCF growth 3Y8.18%
FCF growth 5Y20.39%
OCF growth 1Y14.61%
OCF growth 3Y9.62%
OCF growth 5Y23.91%

EURONEXT NV / ENX.PA FAQ

Can you provide the ChartMill fundamental rating for EURONEXT NV?

ChartMill assigns a fundamental rating of 5 / 10 to ENX.PA.


Can you provide the valuation status for EURONEXT NV?

ChartMill assigns a valuation rating of 5 / 10 to EURONEXT NV (ENX.PA). This can be considered as Fairly Valued.


How profitable is EURONEXT NV (ENX.PA) stock?

EURONEXT NV (ENX.PA) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for ENX stock?

The Price/Earnings (PE) ratio for EURONEXT NV (ENX.PA) is 19.59 and the Price/Book (PB) ratio is 3.25.


What is the financial health of EURONEXT NV (ENX.PA) stock?

The financial health rating of EURONEXT NV (ENX.PA) is 3 / 10.